![A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bad6523d-6b9f-43b0-8662-ea2c7991f945/gr1_lrg.jpg)
A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in
![Efficacy Differences of Pemetrexed by Histology in Pretreated Patients with Stage IIIB/IV Non-small Cell Lung Cancer: Review of Results from an Open-Label Randomized Phase II Study - Journal of Thoracic Oncology Efficacy Differences of Pemetrexed by Histology in Pretreated Patients with Stage IIIB/IV Non-small Cell Lung Cancer: Review of Results from an Open-Label Randomized Phase II Study - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2040424174/2053919182/gr1.jpg)
Efficacy Differences of Pemetrexed by Histology in Pretreated Patients with Stage IIIB/IV Non-small Cell Lung Cancer: Review of Results from an Open-Label Randomized Phase II Study - Journal of Thoracic Oncology
![Impact of pemetrexed chemotherapy on the gut microbiota and intestinal inflammation of patient-lung-derived tumor xenograft (PDX) mouse models | Scientific Reports Impact of pemetrexed chemotherapy on the gut microbiota and intestinal inflammation of patient-lung-derived tumor xenograft (PDX) mouse models | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-65792-6/MediaObjects/41598_2020_65792_Fig1_HTML.png)
Impact of pemetrexed chemotherapy on the gut microbiota and intestinal inflammation of patient-lung-derived tumor xenograft (PDX) mouse models | Scientific Reports
![Prediction of Renal Transporter Mediated Drug-Drug Interactions for Pemetrexed Using Physiologically Based Pharmacokinetic Modeling | Drug Metabolism & Disposition Prediction of Renal Transporter Mediated Drug-Drug Interactions for Pemetrexed Using Physiologically Based Pharmacokinetic Modeling | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/43/3/325/F4.large.jpg)
Prediction of Renal Transporter Mediated Drug-Drug Interactions for Pemetrexed Using Physiologically Based Pharmacokinetic Modeling | Drug Metabolism & Disposition
![Single-dose dexamethasone for the prevention of pemetrexed associated cutaneous adverse reactions | Semantic Scholar Single-dose dexamethasone for the prevention of pemetrexed associated cutaneous adverse reactions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fd80a4acd3a785f3fc19022641cd8c977d2f9049/2-Table1-1.png)
Single-dose dexamethasone for the prevention of pemetrexed associated cutaneous adverse reactions | Semantic Scholar
![Dose response curves of A549 and A549/PEM-1.6,-6.4 and-16 cells to PEM.... | Download Scientific Diagram Dose response curves of A549 and A549/PEM-1.6,-6.4 and-16 cells to PEM.... | Download Scientific Diagram](https://www.researchgate.net/publication/259354816/figure/fig1/AS:616353421619208@1523961515578/Dose-response-curves-of-A549-and-A549-PEM-16-64-and-16-cells-to-PEM-PEM-pemetrexed.png)
Dose response curves of A549 and A549/PEM-1.6,-6.4 and-16 cells to PEM.... | Download Scientific Diagram
البورد العراقي للصيدلة السريرية - Alimta® (pemetrexed) 💎 Note: Start vitamin supplements 1 week before initial pemetrexed dose: Folic acid 400 to 1,000 mcg orally once daily (begin 7 days prior to
![Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non–Small-cell Lung Cancer - Clinical Lung Cancer Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non–Small-cell Lung Cancer - Clinical Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/46553461-d9e6-49e7-9857-291ddb069cb0/gr1_lrg.jpg)
Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non–Small-cell Lung Cancer - Clinical Lung Cancer
![Oral pemetrexed facilitates low-dose metronomic therapy and enhances antitumor efficacy in lung cancer - ScienceDirect Oral pemetrexed facilitates low-dose metronomic therapy and enhances antitumor efficacy in lung cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S016836591830364X-fx1.jpg)